Emerald Bioscience to Present Research Data Related to its Glaucoma ... 2019, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
News
- Emerald Bioscience to Present Research Data Related to its Glaucoma Drug Candidate, NB1111 ...
- Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its ...
- Collaboration with Texas Biomed, SwRI and UT Health San Antonio targets bladder cancer
San Antonio, Texas (October 30, 2019) - The San Antonio Medical Foundation (SAMF) has awarded Texas Biomedical Research Institute Professor ...
- Seattle Genetics: 3Q Earnings Snapshot
The biotechnology company posted revenue of $213.3 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected ...
- Amgen: 3Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $5.74 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks ...